Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Reiterates Outperform on Surface Oncology, Maintains $3 Price Target

Wedbush Reiterates Outperform on Surface Oncology, Maintains $3 Price Target

Wedbush analyst Robert Driscoll reiterates Surface Oncology (NASDAQ:SURF) with a Outperform and maintains $3 price target.

March 10, 2023

1 minute read

Wedbush analyst Robert Driscoll reiterates Surface Oncology (NASDAQ:SURF) with a Outperform and maintains $3 price target.

Despite Macro Pressures, Alibaba Shows Resilience and Potential for Long-Term Value, Says Analyst

August 31, 4:27 PM

Susquehanna analyst Shyam Patil reiterated Alibaba Group Holding Limited (NYSE: BABA) with a Positive

October 11, 8:01 AM

Analysts have provided the following ratings for Invesco (NYSE:IVZ) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

June 10, 9:01 AM

The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it…

July 12, 6:24 AM

Elon Musk has hit back against former President Donald Trump after the latter turned the heat on the Tesla, Inc. (NASDAQ: TSLA) CEO over the weekend.